Screener
Opko Health OPK CapEx
CapEx at other companies
Other financials
Where this comes from
Reported directly by Opko Health in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireProductiveAssets.
The source filing: Opko Health’s 10-Q, filed July 27, 2026.
- Filed
- Jul 27, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-318090
| Line item | For the six months ended June 30, 2026 | For the six months ended June 30, 2025 |
|---|---|---|
| Investments in investees | — | (7,665) |
| Proceeds from sale of equity securities | — | 51,655 |
| Proceeds from the sale of property, plant and equipment | 181 | 181 |
| Capital expenditures | (4,837) | (6,477) |
| Proceeds from Labcorp sale | 18,392 | — |
| Net cash (used in) provided by investing activities | 13,736 | 37,694 |
| Cash flows from financing activities: | ||
| Share repurchase | (17,787) | (18,255) |
Item 1. Financial Statements
FAQ
- What is Opko Health's capex?
- Opko Health (OPK) reported capex of $3M in Q2 2026.
- How has Opko Health's capex changed year-over-year?
- Opko Health's capex decreased by 8.5% year-over-year, from $3.28M to $3M.
- What is the long-term trend for Opko Health's capex?
- Over 4 years (2021 to 2025), Opko Health's capex has grown at a -21.4% compound annual growth rate (CAGR), from $32.16M to $12.28M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Opko Health's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude